Ridhima Biocare
Sodium Valproate (333mg) + Valproic Acid (145mg)
Megprate 333mg/145mg Tablet is a combination of two medicines used to treat epilepsy, a neurological disorder in which there are recurrent episodes of seizures or fits.
Tablet
Megprate 333mg/145mg Tablet is a combination of two medicines used to treat epilepsy, a neurological disorder in which there are recurrent episodes of seizures or fits. It controls the abnormal activity of the brain, relaxes the nerves and hence, prevents seizures or fits.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Megprate 333mg/145mg Tablet is to be taken with food.
No common side effects listed.
It is unsafe to consume alcohol with Megprate 333mg/145mg Tablet.
Megprate 333mg/145mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Megprate 333mg/145mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Megprate 333mg/145mg Tablet is a combination of two antiepileptic medicines: Sodium Valproate and Valproic Acid.
Do not stop taking the medication suddenly without talking to your doctor as it may increase the seizure frequency. Do not take Megprate 333mg/145mg Tablet if you are pregnant or planning to conceive or breastfeeding.